Stereotaxis Price to Sales Ratio vs Receivables Turnover Analysis

STXS Stock

USD 2.64 0.06 2.22%

Stereotaxis financial indicator trend analysis is much more than just breaking down Stereotaxis prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Stereotaxis is a good investment. Please check the relationship between Stereotaxis Price To Sales Ratio and its Receivables Turnover accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stereotaxis. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.

For more information on how to buy Stereotaxis Stock please use our How to Invest in Stereotaxis guide.

Price To Sales Ratio vs Receivables Turnover

Price to Sales Ratio vs Receivables Turnover Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Stereotaxis Price to Sales Ratio account and Receivables Turnover. At this time, the significance of the direction appears to have pay attention.

The correlation between Stereotaxis' Price to Sales Ratio and Receivables Turnover is -0.76. Overlapping area represents the amount of variation of Price to Sales Ratio that can explain the historical movement of Receivables Turnover in the same time period over historical financial statements of Stereotaxis, assuming nothing else is changed. The correlation between historical values of Stereotaxis' Price to Sales Ratio and Receivables Turnover is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price to Sales Ratio of Stereotaxis are associated (or correlated) with its Receivables Turnover. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Receivables Turnover has no effect on the direction of Price to Sales Ratio i.e., Stereotaxis' Price to Sales Ratio and Receivables Turnover go up and down completely randomly.

Correlation Coefficient

-0.76

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Stereotaxis stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Stereotaxis sales, a figure that is much harder to manipulate than other Stereotaxis multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.

Receivables Turnover

Most indicators from Stereotaxis' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Stereotaxis current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stereotaxis. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.

For more information on how to buy Stereotaxis Stock please use our How to Invest in Stereotaxis guide.Selling General Administrative is likely to drop to about 13.3 M in 2024. Issuance Of Capital Stock is likely to drop to about 110.2 K in 2024

Stereotaxis fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Accounts Payable	Cash	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Inventory	Other Current Assets	Property Plant And Equipment Gross
Total Assets		0.75	-0.23	0.2	-0.16	-0.09	0.62	-0.05	0.37	-0.18	-0.06	-0.45	-0.25	0.24	0.63	0.0	-0.43	0.44	0.7	-0.24	0.84	0.03	0.67	0.36	0.59	0.59
Total Stockholder Equity	0.75		-0.03	0.42	0.22	0.29	0.74	-0.52	0.18	-0.77	-0.61	-0.54	-0.73	0.17	0.49	-0.55	-0.84	-0.14	0.81	-0.65	0.94	-0.56	0.64	-0.06	0.16	0.49
Retained Earnings	-0.23	-0.03		0.74	0.92	0.91	-0.64	-0.06	-0.92	-0.2	0.12	-0.09	-0.07	-0.57	-0.41	-0.55	0.0	-0.14	0.11	0.13	0.06	-0.22	-0.61	-0.26	-0.14	-0.45
Non Current Assets Total	0.2	0.42	0.74		0.86	0.86	-0.08	-0.17	-0.67	-0.45	-0.18	-0.33	-0.39	-0.16	0.26	-0.6	-0.27	0.04	0.32	-0.21	0.41	-0.42	-0.1	0.08	-0.24	0.2
Non Currrent Assets Other	-0.16	0.22	0.92	0.86		0.99	-0.35	-0.25	-0.87	-0.49	-0.21	-0.18	-0.36	-0.43	-0.21	-0.74	-0.28	-0.31	0.26	-0.15	0.23	-0.53	-0.4	-0.26	-0.31	-0.2
Other Assets	-0.09	0.29	0.91	0.86	0.99		-0.31	-0.29	-0.84	-0.52	-0.24	-0.2	-0.39	-0.43	-0.21	-0.77	-0.33	-0.32	0.32	-0.18	0.31	-0.56	-0.37	-0.27	-0.25	-0.21
Common Stock Shares Outstanding	0.62	0.74	-0.64	-0.08	-0.35	-0.31		-0.4	0.63	-0.48	-0.58	-0.36	-0.52	0.5	0.72	-0.09	-0.62	-0.05	0.48	-0.65	0.58	-0.32	0.92	0.14	0.12	0.78
Non Current Liabilities Total	-0.05	-0.52	-0.06	-0.17	-0.25	-0.29	-0.4		-0.04	0.73	0.82	-0.2	0.31	0.16	-0.02	0.53	0.76	0.49	-0.38	0.93	-0.41	0.72	-0.28	0.47	0.21	-0.07
Other Stockholder Equity	0.37	0.18	-0.92	-0.67	-0.87	-0.84	0.63	-0.04		0.05	-0.17	0.01	-0.03	0.62	0.34	0.44	-0.11	0.11	0.0	-0.18	0.1	0.13	0.58	0.27	0.17	0.34
Total Liab	-0.18	-0.77	-0.2	-0.45	-0.49	-0.52	-0.48	0.73	0.05		0.84	0.38	0.86	-0.06	-0.1	0.82	0.83	0.63	-0.54	0.73	-0.59	0.88	-0.28	0.39	0.34	-0.13
Short Long Term Debt Total	-0.06	-0.61	0.12	-0.18	-0.21	-0.24	-0.58	0.82	-0.17	0.84		-0.03	0.64	-0.16	-0.19	0.57	0.83	0.65	-0.37	0.87	-0.42	0.88	-0.33	0.34	0.44	-0.25
Other Current Liab	-0.45	-0.54	-0.09	-0.33	-0.18	-0.2	-0.36	-0.2	0.01	0.38	-0.03		0.69	-0.31	-0.3	0.33	0.19	0.01	-0.41	-0.07	-0.46	0.09	-0.39	-0.14	-0.12	-0.3
Total Current Liabilities	-0.25	-0.73	-0.07	-0.39	-0.36	-0.39	-0.52	0.31	-0.03	0.86	0.64	0.69		-0.27	-0.22	0.7	0.65	0.53	-0.49	0.4	-0.54	0.68	-0.33	0.19	0.29	-0.25
Other Liab	0.24	0.17	-0.57	-0.16	-0.43	-0.43	0.5	0.16	0.62	-0.06	-0.16	-0.31	-0.27		0.51	0.21	-0.05	0.11	-0.06	-0.08	0.04	-0.06	0.41	0.36	-0.22	0.45
Property Plant And Equipment Net	0.63	0.49	-0.41	0.26	-0.21	-0.21	0.72	-0.02	0.34	-0.1	-0.19	-0.3	-0.22	0.51		0.14	-0.2	0.46	0.22	-0.35	0.39	0.0	0.74	0.51	0.03	0.96
Current Deferred Revenue	0.0	-0.55	-0.55	-0.6	-0.74	-0.77	-0.09	0.53	0.44	0.82	0.57	0.33	0.7	0.21	0.14		0.66	0.57	-0.53	0.45	-0.48	0.79	-0.01	0.54	0.32	0.1
Net Debt	-0.43	-0.84	0.0	-0.27	-0.28	-0.33	-0.62	0.76	-0.11	0.83	0.83	0.19	0.65	-0.05	-0.2	0.66		0.42	-0.82	0.81	-0.79	0.77	-0.46	0.37	0.0	-0.27
Accounts Payable	0.44	-0.14	-0.14	0.04	-0.31	-0.32	-0.05	0.49	0.11	0.63	0.65	0.01	0.53	0.11	0.46	0.57	0.42		-0.04	0.35	0.01	0.69	0.22	0.57	0.44	0.35
Cash	0.7	0.81	0.11	0.32	0.26	0.32	0.48	-0.38	0.0	-0.54	-0.37	-0.41	-0.49	-0.06	0.22	-0.53	-0.82	-0.04		-0.44	0.91	-0.39	0.47	-0.21	0.44	0.28
Long Term Debt	-0.24	-0.65	0.13	-0.21	-0.15	-0.18	-0.65	0.93	-0.18	0.73	0.87	-0.07	0.4	-0.08	-0.35	0.45	0.81	0.35	-0.44		-0.51	0.71	-0.52	0.28	0.21	-0.4
Cash And Short Term Investments	0.84	0.94	0.06	0.41	0.23	0.31	0.58	-0.41	0.1	-0.59	-0.42	-0.46	-0.54	0.04	0.39	-0.48	-0.79	0.01	0.91	-0.51		-0.42	0.55	-0.04	0.39	0.39
Net Receivables	0.03	-0.56	-0.22	-0.42	-0.53	-0.56	-0.32	0.72	0.13	0.88	0.88	0.09	0.68	-0.06	0.0	0.79	0.77	0.69	-0.39	0.71	-0.42		-0.11	0.29	0.51	-0.07
Common Stock Total Equity	0.67	0.64	-0.61	-0.1	-0.4	-0.37	0.92	-0.28	0.58	-0.28	-0.33	-0.39	-0.33	0.41	0.74	-0.01	-0.46	0.22	0.47	-0.52	0.55	-0.11		0.2	0.25	0.8
Inventory	0.36	-0.06	-0.26	0.08	-0.26	-0.27	0.14	0.47	0.27	0.39	0.34	-0.14	0.19	0.36	0.51	0.54	0.37	0.57	-0.21	0.28	-0.04	0.29	0.2		0.12	0.49
Other Current Assets	0.59	0.16	-0.14	-0.24	-0.31	-0.25	0.12	0.21	0.17	0.34	0.44	-0.12	0.29	-0.22	0.03	0.32	0.0	0.44	0.44	0.21	0.39	0.51	0.25	0.12		0.08
Property Plant And Equipment Gross	0.59	0.49	-0.45	0.2	-0.2	-0.21	0.78	-0.07	0.34	-0.13	-0.25	-0.3	-0.25	0.45	0.96	0.1	-0.27	0.35	0.28	-0.4	0.39	-0.07	0.8	0.49	0.08

Click cells to compare fundamentals

Stereotaxis Account Relationship Matchups

Stereotaxis fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	43.6M	55.5M	61.0M	53.4M	41.9M	33.6M
Total Stockholder Equity	28.5M	40.2M	39.4M	31.9M	16.3M	10.1M
Retained Earnings	(481.3M)	(488.0M)	(498.7M)	(517.0M)	(537.7M)	(564.6M)
Non Current Assets Total	4.8M	503.6K	9.6M	10.2M	8.6M	4.7M
Non Currrent Assets Other	218.1K	308.5K	278.2K	208K	356K	338.2K
Other Assets	218.1K	2.5M	1.2M	952K	1.0	0.95
Common Stock Shares Outstanding	63.1M	72.7M	75.6M	76.1M	80.7M	84.7M
Liabilities And Stockholders Equity	43.6M	55.5M	61.0M	53.4M	41.9M	33.6M
Non Current Liabilities Total	2.9M	1.7M	8.3M	7.2M	6.7M	9.6M
Other Stockholder Equity	504.0M	522.5M	532.4M	543.2M	553.9M	393.4M
Total Liab	15.1M	15.2M	21.6M	21.5M	20.0M	32.1M
Other Current Liab	2.7M	3.2M	2.5M	3.3M	3.0M	5.8M
Total Current Liabilities	12.2M	13.6M	13.3M	14.3M	13.2M	17.1M
Other Liab	809.8K	680.1K	2.5M	1.7M	2.0M	1.1M
Property Plant And Equipment Net	4.5M	195.1K	8.4M	9.2M	8.3M	8.7M
Current Deferred Revenue	5.1M	5.3M	6.3M	7.3M	6.7M	6.9M
Net Debt	(25.8M)	(39.5M)	(32.6M)	(2.7M)	(14.3M)	(13.6M)
Accounts Payable	2.1M	1.6M	4.2M	3.3M	3.2M	2.8M
Cash	30.2M	43.9M	38.7M	8.6M	19.8M	20.7M
Cash And Short Term Investments	30.2M	43.9M	38.7M	28.4M	19.8M	18.2M
Net Receivables	5.3M	3.5M	5.4M	5.1M	3.8M	5.9M
Common Stock Total Equity	68.5K	73.7K	74.6K	75K	86.3K	90.6K
Inventory	1.8M	3.3M	4.4M	7.9M	8.4M	4.3M
Other Current Assets	1.5M	4.2M	2.4M	1.3M	1.2M	1.8M
Property Plant And Equipment Gross	4.5M	2.4M	8.4M	9.2M	12.2M	12.8M
Total Current Assets	38.8M	55.0M	51.4M	43.2M	33.3M	30.2M
Common Stock	68.5K	73.7K	74.6K	75K	81K	43.9K
Property Plant Equipment	250.4K	195.1K	8.4M	3.8M	3.4M	2.2M
Net Tangible Assets	28.5M	40.2M	33.8M	31.9M	36.7M	38.5M
Retained Earnings Total Equity	(481.3M)	(488.0M)	(498.7M)	(517.0M)	(465.3M)	(488.5M)
Capital Surpluse	504.2M	522.7M	532.6M	543.4M	625.0M	508.0M

Currently Active Assets on Macroaxis

LTC	Litecoin
STETH	Staked Ether
LINK	Chainlink
XLM	Stellar
CRO	Cronos

When determining whether Stereotaxis is a strong investment it is important to analyze Stereotaxis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Stereotaxis' future performance. For an informed investment choice regarding Stereotaxis Stock, refer to the following important reports:

How To Invest In Stereotaxis

Details

Is Stereotaxis Stock a good investment?

Details

What is Stereotaxis' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stereotaxis. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.

For more information on how to buy Stereotaxis Stock please use our How to Invest in Stereotaxis guide.

You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Complementary Tools for Stereotaxis Stock analysis

When running Stereotaxis' price analysis, check to measure Stereotaxis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stereotaxis is operating at the current time. Most of Stereotaxis' value examination focuses on studying past and present price action to predict the probability of Stereotaxis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stereotaxis' price. Additionally, you may evaluate how the addition of Stereotaxis to your portfolios can decrease your overall portfolio volatility.

	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories
	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges

Is Stereotaxis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stereotaxis. If investors know Stereotaxis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stereotaxis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.27)

Revenue Per Share

0.332

Quarterly Revenue Growth

(0.38)

Return On Assets

(0.29)

Return On Equity

(0.77)

The market value of Stereotaxis is measured differently than its book value, which is the value of Stereotaxis that is recorded on the company's balance sheet. Investors also form their own opinion of Stereotaxis' value that differs from its market value or its book value, called intrinsic value, which is Stereotaxis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stereotaxis' market value can be influenced by many factors that don't directly affect Stereotaxis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Stereotaxis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Stereotaxis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stereotaxis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Stereotaxis Price to Sales Ratio vs Receivables Turnover Analysis

Price To Sales Ratio vs Receivables Turnover

Price to Sales Ratio vs Receivables Turnover Correlation Analysis

Correlation Coefficient

Price To Sales Ratio

Receivables Turnover

Stereotaxis fundamental ratios Correlations

Stereotaxis Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Stereotaxis fundamental ratios Accounts

Currently Active Assets on Macroaxis

Complementary Tools for Stereotaxis Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Assets	+ 0.99	Non Currrent Assets Other
Property Plant And Equipment Gross	+ 0.96	Property Plant And Equipment Net
Cash And Short Term Investments	+ 0.94	Total Stockholder Equity
Long Term Debt	+ 0.93	Non Current Liabilities Total
Non Currrent Assets Other	+ 0.92	Retained Earnings
Common Stock Total Equity	+ 0.92	Common Stock Shares Outstanding

Other Stockholder Equity	- 0.92	Retained Earnings
Other Stockholder Equity	- 0.87	Non Currrent Assets Other
Other Stockholder Equity	- 0.84	Other Assets
Net Debt	- 0.84	Total Stockholder Equity
Cash	- 0.82	Net Debt
Cash And Short Term Investments	- 0.79	Net Debt